Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Centers for Disease Control and Prevention, Drugs (Pharmaceuticals), Elderly, Food and Drug Administration, GSK PLC, Guillain-Barre Syndrome, Pfizer Inc, Respiratory Syncytial Virus (RSV), Vaccination and Immunization, Viruses
←Amanda Gorman’s Book Sales Soar Amid Florida Bans Of Her Work
Conservatives Complain Chick-fil-A Has ‘Gone Woke’ Over D.E.I.→

More posts

  • Travis Kelce shares first details from his wedding to Taylor Swift – ‘Best night of my life’

  • Virginia woman says ICE agent pointed gun at her, denies trying to run over agents

  • The 3 Hair-Care Habits I Picked Up at a Korean Scalp Spa

  • Bill Gates’ Daughter Phoebe’s App Accused of ‘Cookie Stuffing’

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube